| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.02381-05 |
| P8608 | Fatcat ID | release_mzsw4sprsza6ja32o25trjlph4 |
| P932 | PMC publication ID | 1488970 |
| P698 | PubMed publication ID | 16775317 |
| P50 | author | Adolfo García-Sastre | Q4684232 |
| Stuart C Sealfon | Q58051864 | ||
| Ana Fernández-Sesma | Q37368173 | ||
| P2093 | author name string | Thomas M Moran | |
| Tony Yuen | |||
| Svetlana Marukian | |||
| Man-Seong Park | |||
| Barbara J Ebersole | |||
| Dorothy Kaminski | |||
| P2860 | cites work | Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells | Q24307725 |
| Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells | Q27469379 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein | Q28140837 | ||
| Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. | Q28609759 | ||
| A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice | Q28609778 | ||
| Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs | Q28609836 | ||
| Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature | Q71656310 | ||
| IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells | Q74145377 | ||
| Dendritic cell development and survival require distinct NF-kappaB subunits | Q77704364 | ||
| Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18 | Q81158144 | ||
| Viral mechanisms of immune evasion | Q93939877 | ||
| Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems | Q29039793 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Interleukin-12 and the regulation of innate resistance and adaptive immunity | Q29614602 | ||
| Dendritic cells: specialized and regulated antigen processing machines | Q29617085 | ||
| Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection | Q30465682 | ||
| Dendritic cells maximize the memory CD8 T cell response to infection | Q33801974 | ||
| Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein | Q33810694 | ||
| Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs | Q33843120 | ||
| Attenuation of equine influenza viruses through truncations of the NS1 protein | Q33843410 | ||
| Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach | Q33895154 | ||
| Multiple control of interleukin-8 gene expression | Q34648084 | ||
| Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses | Q34669736 | ||
| Influenza vaccines: present and future | Q34717840 | ||
| Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors | Q35848582 | ||
| Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection | Q35978569 | ||
| The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation | Q36402640 | ||
| Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. | Q37349027 | ||
| Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. | Q37596474 | ||
| Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. | Q38973017 | ||
| Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells | Q39579384 | ||
| Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon | Q39593618 | ||
| Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays | Q39607930 | ||
| The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors | Q39685168 | ||
| Newcastle disease virus V protein is a determinant of host range restriction | Q39864222 | ||
| A bispecific antibody recognizing influenza A virus M2 protein redirects effector cells to inhibit virus replication in vitro. | Q39875306 | ||
| Molecular mechanisms of variation in influenza viruses | Q40102702 | ||
| Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex | Q40629393 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection | Q40937084 | ||
| Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus | Q42723106 | ||
| Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways | Q45537161 | ||
| Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor | Q45772727 | ||
| TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses | Q47892185 | ||
| Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. | Q51349178 | ||
| Distinct patterns and kinetics of chemokine production regulate dendritic cell function. | Q54093362 | ||
| Type I Interferon Induction Pathway, but Not Released Interferon, Participates in the Maturation of Dendritic Cells Induced by Negative‐Strand RNA Viruses | Q56877437 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6295-6304 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Influenza virus evades innate and adaptive immunity via the NS1 protein | |
| P478 | volume | 80 |
| Q37713963 | 17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs. |
| Q60925671 | A Mechanism Underlying Attenuation of Recombinant Influenza A Viruses Carrying Reporter Genes |
| Q90401267 | A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection |
| Q54518448 | A comprehensive evaluation of human plasmacytoid dendritic cells using small volumes of human blood. |
| Q36670254 | A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity |
| Q37191920 | Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain |
| Q37566104 | Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency |
| Q30377447 | Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. |
| Q24328769 | Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen |
| Q37123453 | Alphacoronavirus protein 7 modulates host innate immune response |
| Q36086374 | An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs |
| Q38218674 | Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making? |
| Q34871428 | Antiviral-activated dendritic cells: a paracrine-induced response state |
| Q30410882 | Apoptosis, cytokine and chemokine induction by non-structural 1 (NS1) proteins encoded by different influenza subtypes |
| Q34275252 | Appearance of L90I and N205S Mutations in Effector Domain of NS1 Gene of pdm (09) H1N1 Virus from India during 2009-2013. |
| Q33778227 | Association of RIG-I with innate immunity of ducks to influenza |
| Q33637378 | Attenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3 |
| Q40310176 | Avian influenza virus directly infects human natural killer cells and inhibits cell activity |
| Q30363622 | Avian influenza: should China be alarmed? |
| Q36626264 | Boolean Modeling of Cellular and Molecular Pathways Involved in Influenza Infection |
| Q38613824 | Bunyaviruses and the type I interferon system |
| Q37158129 | Cell-to-cell communication: time and length scales of ligand internalization in cultures of suspended cells. |
| Q82461827 | Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens |
| Q34785367 | Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry |
| Q30354070 | Closely related influenza viruses induce contrasting respiratory tract immunopathology |
| Q41979482 | Combinatorial cytokine code generates anti-viral state in dendritic cells |
| Q35745527 | Comparative analysis of anti-viral transcriptomics reveals novel effects of influenza immune antagonism |
| Q38923317 | Comparative analysis of selected innate immune-related genes following infection of immortal DF-1 cells with highly pathogenic (H5N1) and low pathogenic (H9N2) avian influenza viruses |
| Q64098233 | Consensus and variations in cell line specificity among human metapneumovirus strains |
| Q30384675 | Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. |
| Q42282010 | Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells |
| Q40882442 | Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines |
| Q36357778 | Cross-presenting CD103+ dendritic cells are protected from influenza virus infection |
| Q30363164 | Cytokine Expression at Different Stages of Influenza A(H1N1)pdm09 Virus Infection in the Porcine Lung, Using Laser Capture Microdissection. |
| Q36579451 | Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation |
| Q21131391 | DENV inhibits type I IFN production in infected cells by cleaving human STING |
| Q37945184 | Dendritic Cells in Innate and Adaptive Immune Responses against Influenza Virus |
| Q37945301 | Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? |
| Q37754636 | Dendritic cells in viral bronchiolitis. |
| Q38873923 | Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. |
| Q37436763 | Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects |
| Q40338983 | Dengue virus inhibits the production of type I interferon in primary human dendritic cells |
| Q90616770 | Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1 |
| Q38513218 | Differential host gene expression in cells infected with highly pathogenic H5N1 avian influenza viruses |
| Q34104767 | Early activation of MAP kinases by influenza A virus X-31 in murine macrophage cell lines |
| Q39603352 | Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells |
| Q42779734 | Effects of receptor binding specificity of avian influenza virus on the human innate immune response |
| Q36949866 | Emerging role of dendritic cells in respiratory viral infection |
| Q91925599 | Endothelial IL-8 induced by porcine circovirus type 2 affects dendritic cell maturation and antigen-presenting function |
| Q43251031 | Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function |
| Q30399806 | Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus |
| Q37001966 | Estrogen inhibits dendritic cell maturation to RNA viruses. |
| Q34336441 | Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice |
| Q38061423 | Evasion of influenza A viruses from innate and adaptive immune responses. |
| Q33965443 | Evasion of innate and adaptive immune responses by influenza A virus |
| Q55554478 | Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy. |
| Q98721479 | Experimental validation of influenza A virus matrix protein (M1) interaction with host cellular alpha enolase and pyruvate kinase |
| Q92538061 | Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo |
| Q40150645 | Functional Evolution of Influenza Virus NS1 Protein in Currently Circulating Human 2009 Pandemic H1N1 Viruses. |
| Q30363578 | Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus. |
| Q31037274 | Gamma-irradiated influenza virus uniquely induces IFN-I mediated lymphocyte activation independent of the TLR7/MyD88 pathway |
| Q33329258 | Gene expression analyses in Atlantic salmon challenged with infectious salmon anemia virus reveal differences between individuals with early, intermediate and late mortality |
| Q90148702 | Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines |
| Q30357267 | Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011 |
| Q36132799 | Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses |
| Q36559887 | Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy |
| Q30986632 | Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site |
| Q52647758 | Host Immune Response to Influenza A Virus Infection. |
| Q89658184 | Host Innate Immune Response of Geese Infected with Clade 2.3.4.4 H5N6 Highly Pathogenic Avian Influenza Viruses |
| Q37392028 | Host responses from innate to adaptive immunity after vaccination: molecular and cellular events |
| Q30377316 | Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses. |
| Q36625188 | IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8⁺ T cell responses to influenza A virus |
| Q42875392 | IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection |
| Q58566718 | Identification of Amino Acid Residues Responsible for Inhibition of Host Gene Expression by Influenza A H9N2 NS1 Targeting of CPSF30 |
| Q28075495 | Immune Responses to Influenza Virus and Its Correlation to Age and Inherited Factors |
| Q33647894 | Immune response modeling of interferon beta-pretreated influenza virus-infected human dendritic cells. |
| Q33614507 | Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses |
| Q36837134 | Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design |
| Q37030332 | Immunogenetics of seasonal influenza vaccine response |
| Q27006825 | Immunological features of the non-structural proteins of porcine reproductive and respiratory syndrome virus |
| Q35005894 | Impaired T cell function in argininosuccinate synthetase deficiency |
| Q48292469 | In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4+ T Lymphocytes |
| Q42934955 | Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway |
| Q38178692 | Inflammasomes in antiviral immunity: clues for influenza vaccine development |
| Q33489629 | Influence of dendritic cells on viral pathogenicity |
| Q35610815 | Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome |
| Q36667794 | Influenza A virus NS1 induces G0/G1 cell cycle arrest by inhibiting the expression and activity of RhoA protein |
| Q24302191 | Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling |
| Q34192846 | Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells |
| Q30404670 | Influenza A viruses: new research developments |
| Q28748500 | Influenza Virus Non-Structural Protein 1 (NS1) Disrupts Interferon Signaling |
| Q33397737 | Influenza a virus induces an immediate cytotoxic activity in all major subsets of peripheral blood mononuclear cells |
| Q38737075 | Influenza infection in human host: challenges in making a better influenza vaccine |
| Q38188084 | Influenza reverse genetics: dissecting immunity and pathogenesis |
| Q89041842 | Influenza vaccine failure: failure to protect or failure to understand? |
| Q42546477 | Influenza virus directly infects human natural killer cells and induces cell apoptosis |
| Q38211561 | Influenza viruses and mRNA splicing: doing more with less |
| Q35200858 | Influenza-induced innate immunity: regulators of viral replication, respiratory tract pathology & adaptive immunity |
| Q40338951 | Inhibition of human natural killer cell activity by influenza virions and hemagglutinin |
| Q35914316 | Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels |
| Q24611465 | Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex |
| Q37362928 | Innate immune control and regulation of influenza virus infections |
| Q33646273 | Innate immune evasion strategies of influenza viruses |
| Q28727437 | Innate immune induction and influenza protection elicited by a response-selective agonist of human C5a |
| Q37226509 | Innate immune modulation by RNA viruses: emerging insights from functional genomics |
| Q30365302 | Innate immune sensing and response to influenza. |
| Q24627203 | Innate immunity evasion by Dengue virus |
| Q27489605 | Innate immunity to influenza virus: implications for future therapy |
| Q33381621 | Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus |
| Q36127475 | Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection |
| Q36797689 | Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells |
| Q40594425 | Kupffer cells modulate hepatic fatty acid oxidation during infection with PR8 influenza. |
| Q35634308 | M135R is a novel cell surface virulence factor of myxoma virus |
| Q30359771 | Model of influenza A virus infection: dynamics of viral antagonism and innate immune response. |
| Q34325485 | Modeling within-host dynamics of influenza virus infection including immune responses |
| Q34253570 | Molecular mechanisms of viral inhibitors of RIG-I-like receptors |
| Q30361157 | Multiple anti-interferon actions of the influenza A virus NS1 protein |
| Q30394706 | NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets |
| Q36845814 | Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells |
| Q34190582 | Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study |
| Q24602706 | Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells |
| Q37033299 | Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses |
| Q47552020 | PDZ proteins are expressed and regulated in antigen-presenting cells and are targets of influenza A virus |
| Q47569692 | Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death. |
| Q30427596 | Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice |
| Q36010636 | Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection |
| Q35943423 | Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection |
| Q41174221 | Protection of human myeloid dendritic cell subsets against influenza A virus infection is differentially regulated upon TLR stimulation |
| Q35893651 | Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus. |
| Q41821208 | Recombinant influenza A viruses with enhanced levels of PB1 and PA viral protein expression |
| Q30431448 | Reconstruction of regulatory networks through temporal enrichment profiling and its application to H1N1 influenza viral infection. |
| Q33591243 | Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology |
| Q40184517 | Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts |
| Q56787459 | Role of the influenza virus nonstructural 1 protein in evasion of immunity |
| Q35184087 | Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis |
| Q37247935 | Simulation and prediction of the adaptive immune response to influenza A virus infection |
| Q41491260 | Single-cell analysis shows that paracrine signaling by first responder cells shapes the interferon-β response to viral infection. |
| Q92528878 | Structural and Functional Properties of the Capsid Protein of Dengue and Related Flavivirus |
| Q27652280 | Structural basis for dsRNA recognition by NS1 protein of influenza A virus |
| Q84106002 | Structured regulation of inflammation during respiratory viral infection |
| Q30395437 | Suppression of Rac1 Signaling by Influenza A Virus NS1 Facilitates Viral Replication |
| Q30424121 | Surface glycoproteins determine the feature of the 2009 pandemic H1N1 virus |
| Q30205195 | Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses |
| Q41786139 | TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFkB-dependent pathways |
| Q37776665 | The Battle between Virus and Host: Modulation of Toll-Like Receptor Signaling Pathways by Virus Infection |
| Q39188991 | The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors |
| Q33288729 | The Ebola virus VP35 protein is a suppressor of RNA silencing |
| Q41361470 | The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells |
| Q35963811 | The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways |
| Q35947867 | The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells |
| Q34455955 | The RNA-binding domain of influenzavirus non-structural protein-1 cooperatively binds to virus-specific RNA sequences in a structure-dependent manner |
| Q38161762 | The amazing innate immune response to influenza A virus infection |
| Q35000547 | The functional impairment of natural killer cells during influenza virus infection |
| Q34171512 | The genomic rate of molecular adaptation of the human influenza A virus |
| Q36055988 | The human side of influenza |
| Q33939684 | The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein |
| Q36916396 | The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation |
| Q36779482 | The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology. |
| Q33533335 | The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells |
| Q35963333 | Time and length scales of autocrine signals in three dimensions. |
| Q59356280 | Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection |
| Q35213081 | Transforming growth factor-beta-activated kinase 1 regulates natural killer cell-mediated cytotoxicity and cytokine production |
| Q42712613 | Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge |
| Q24298547 | Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response |
| Q38835082 | Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection. |
| Q36926779 | Viral stress-inducible genes. |
| Q36750723 | Viral suppression of the interferon system |
| Q36729667 | Viruses and dendritic cells: enemy mine |
| Q36394947 | Visualization of early influenza A virus trafficking in human dendritic cells using STED microscopy. |
| Q30371269 | Why is coinfection with influenza virus and bacteria so difficult to control? |
| Q30409798 | p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. |
Search more.